Do Gender Quotas Really Reduce Bias? Evidence from a Policy Experiment in Southern Africa
Journal of Experimental Political Science · 2018 · 5 (3) · 182-194
DOI: 10.1017/xps.2018.8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Political Science, online erschienen am 10.04.2018. Verfasst von Amanda Clayton. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Abstract (Originalsprache)
A well-documented policy experiment reserving seats for women village leaders in India suggests quotas decrease citizens’ gender stereotypes and increase career aspirations and educational attainment for young women and girls. But do these results generalize to cases outside of India? And how long must quotas be in place to observe the positive effects of women’s leadership? I present data from a similar policy experiment in the southern African nation of Lesotho to test whether citizens express less gender bias after 6-years of exposure to quota-elected women village representatives. Relying on surveys and data from in-field Implicit Association Tests, I find no evidence that the quota reduced average measures of citizen gender bias, although I do find weak evidence that the quota caused young women in particular to exhibit more gender-egalitarian attitudes, both explicit and implicit.
Zitieren
APA
Clayton, A. (2018). Do Gender Quotas Really Reduce Bias? Evidence from a Policy Experiment in Southern Africa. Journal of Experimental Political Science, 5(3), 182-194. https://doi.org/10.1017/xps.2018.8
Vancouver
Clayton A. Do Gender Quotas Really Reduce Bias? Evidence from a Policy Experiment in Southern Africa. Journal of Experimental Political Science. 2018;5(3):182-194. doi:10.1017/xps.2018.8
BibTeX
@article{Clayton2018,
author = {Clayton, Amanda},
title = {Do Gender Quotas Really Reduce Bias? Evidence from a Policy Experiment in Southern Africa},
journal = {Journal of Experimental Political Science},
year = {2018},
volume = {5},
number = {3},
pages = {182--194},
doi = {10.1017/xps.2018.8}
}
EUVIMED